ASX 200 morning report – flight to quality, small-caps tumble
Drew Meredith, CFP
September 10, 2021
The S&P/ASX 200 (ASX:XJO) suffered its worst day in months
ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
The S&P/ASX 200 (ASX:XJO) suffered its worst day in months
The S&P/ASX 200 (ASX:XJO) overcame another 8% fall in the
The Resmed CDI (ASX: RMD) share price has been a
Global healthcare leader Resmed CDI (ASX: RMD) recorded a 14%
The S&P/ASX 200 (ASX: XJO) managed a 0.2% gain on
Shares in healthcare giant CSL Limited (ASX: CSL) have made
The S&P/ASX 200 (ASX: XJO) finished 0.1% higher on Friday
The ResMed CDI (ASX: RMD) share price is in the
There are some quality ASX tech shares that Aussies can
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
